Page last updated: 2024-11-12

cis-3,4',5-trimethoxy-3'-aminostilbene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cis-3,4',5-trimethoxy-3'-aminostilbene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10446642
CHEMBL ID119934
SCHEMBL ID1284983
MeSH IDM0521661

Synonyms (8)

Synonym
CHEMBL119934
586410-12-0
cis-3,4',5-trimethoxy-3'-aminostilbene
SCHEMBL1284983
5-[(z)-2-(3,5-dimethoxyphenyl)ethenyl]-2-methoxyaniline
cis-3,5,4'-trimethoxy-3'-amino stilbene
(z)-5-(3,5-dimethoxystyryl)-2-methoxyaniline
cis-3,4?,5-trimethoxy-3?-aminostilbene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID83141In vitro inhibitory concentration against proliferation of HL60R cells along with 5 (uM) verapamil2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID82982In vitro inhibitory concentration against proliferation of HL60 cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID1164173Induction of apoptosis in human K562 cells using annexin-V/PI staining by flow cytometry2014ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.
AID1164172Antiproliferative activity against human K562 cells assessed as growth inhibition after 48 hrs by trypan blue dye exclusion method2014ACS medicinal chemistry letters, Sep-11, Volume: 5, Issue:9
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.
AID83137In vitro concentration required to induce apoptosis in HL60R cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID348172Solubility in water2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Design, synthesis and biological evaluation of novel stilbene-based antitumor agents.
AID82976In vitro concentration required to induce apoptosis in HL60 cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID83140In vitro inhibitory concentration against proliferation of HL60R cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.02 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]